Cathie Wood: Navigating Innovation at the Crossroads Summit 2024

Renowned investor Cathie Wood, known for her bold bets on disruptive technologies, will share her insights at the upcoming Crossroads Summit 2024. Learn how she’s finding opportunities in the rapidly evolving world of AI, genomics, and other groundbreaking advancements. Join the event and gain valuable perspectives on embracing disruption as a catalyst for investment success.

Ark Invest Makes Major Moves: Amazon, Robinhood, Block, AMD, Meta, Tesla & Palantir Trades

Cathie Wood’s Ark Invest has been busy making significant trades in a variety of tech giants, including Amazon, Robinhood, Block, AMD, Meta, Tesla, and Palantir. These trades, executed across Ark Invest’s diverse ETFs, reflect the firm’s bullish outlook on these companies’ future growth prospects. Discover the rationale behind each trade and how they align with Ark Invest’s investment strategy.

Ark Invest Bets on Amazon’s Nuclear Energy Future: Is This a Turnaround or a Gamble?

Cathie Wood’s Ark Invest has made a significant purchase of Amazon shares, fueling speculation about the tech giant’s potential foray into nuclear energy. This move comes amidst Amazon’s recent hiring of a nuclear engineer and its expanding collaboration with Intel, suggesting a shift in its long-term energy strategy. While some see it as a sign of Amazon’s potential turnaround, others question the risk involved.

Cathie Wood’s Ark Invest Makes Major Moves: Block, Moderna, and Robinhood Shares Sold

Cathie Wood’s Ark Invest has been active in the market this week, making significant trades involving Block Inc (SQ), Moderna Inc (MRNA), and Robinhood Markets Inc (HOOD). The fund sold off shares of Block, despite the company’s recent positive second-quarter earnings. Ark also sold off shares of Moderna, following the company’s announcement of its post-Covid roadmap. Additionally, the fund divested from Robinhood, despite the platform’s expansion into futures and index options trading. Ark Invest also made purchases in several other companies, including Intellia Therapeutics, CRISPR Therapeutics, and Tempus AI.

Scroll to Top